Results 151 to 160 of about 137,343 (204)

[Vogt-Koyanagi-Harada syndrome].

open access: yesArquivos brasileiros de oftalmologia, 1971
V A, Centurión, J J, Areas
openaire   +1 more source

Vogt-Koyanagi-Harada disease [PDF]

open access: yesPractical Neurology, 2019
Vogt-Koyanagi-Harada disease is a rare, multisystem, autoimmune disorder with numerous clinical manifestations, mediated through a T-helper 1 response against melanocytes in the eye, inner ear, central nervous system, hair and skin. We describe a 20-year-old British–Honduran man with recent worsening headache and photophobia, vomiting and visual ...
Duncan Street   +3 more
core   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Vogt-Koyanagi-Harada Syndrome

Current Eye Research, 2008
Vogt-Koyanagi-Harada syndrome is a bilateral, chronic, diffuse granulomatous panuveitis frequently associated with neurological, auditory, and integumentary manifestations. It is also one of the most common forms of uveitis among pigmented races including Chinese patients.This article reviews the current developments of Vogt-Koyanagi-Harada syndrome ...
Peizeng Yang
exaly   +3 more sources

Vogt-Koyanagi-Harada disease

Survey of Ophthalmology, 2017
Vogt-Koyanagi-Harada disease, a severe bilateral granulomatous intraocular inflammation associated with serous retinal detachments, disk edema, and vitritis, with eventual development of a sunset glow fundus, is an autoimmune inflammatory condition mediated by T cells that target melanocytes in individuals susceptible to the disease.
Narsing Rao
exaly   +3 more sources

Vogt-Koyanagi-Harada Disease in Thailand

Ocular Immunology and Inflammation, 2012
To determine clinical characteristics and rate of ocular complications in patients with Vogt-Koyanagi-Harada disease (VKH).The authors performed a retrospective review of 48 consecutive patients (92 affected eyes) diagnosed with VKH. Demographic data, clinical manifestations, treatment modalities, and ocular complications were registered.VKH ...
Aniki Rothova   +2 more
exaly   +4 more sources

Vogt-Koyanagi-Harada Disease

Seminars in Ophthalmology, 2005
Vogt-Koyanagi-Harada disease (VKH) is a multisystem autoimmune disorder principally affecting pigmented tissues in the ocular, auditory, integumentary and central nervous systems. Patients are typically 20 to 50 years old and have no history of either surgical or accidental ocular trauma. Pigmented races are more commonly affected. Depending on revised
Francisco Max, Damico   +2 more
openaire   +4 more sources

Vogt-Koyanagi-Harada disease

Current Opinion in Ophthalmology, 2021
Purpose of review Here, we provide an overview of Vogt-Koyanagi-Harada disease (VKH), including recent updates in our understanding of disease pathophysiology, classification and therapeutics. Recent findings Advancements in bioinformatics, metabolomics and genomics investigations ...
Ashlin, Joye, Eric, Suhler
openaire   +3 more sources

Vogt-Koyanagi-Harada Syndrome

International Ophthalmology Clinics, 1995
The Vogt-Koyanagi-Harada syndrome (VKH) is a bilateral, diffuse granulomatous uveitis associated with poliosis, vitiligo, alopecia, and central nervous system and auditory signs. These manifestations are variable and race dependent. This inflammatory syndrome is probably the result of an autoimmune mechanism, influenced by genetic factors, and appears ...
R S, Moorthy, H, Inomata, N A, Rao
openaire   +3 more sources

Vogt-Koyanagi-Harada Disease

International Ophthalmology Clinics, 2006
Vogt-Koyanagi-Harada (VKH) disease, also known as uveomeningitic syndrome, is an idiopathic multisystem inflammatory disease with bilateral uveitis. Patients with bilateral anterior uveitis with vitiligo, poliosis, alopecia, and dysacousia were first described by Vogt in 1906 and then Koyanagi in 1929.
Christopher M, Andreoli   +1 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy